Ali Nili
Overview
Explore the profile of Ali Nili including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
113
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rakhshandehroo T, Mantri S, Moravej H, Louis B, Salehi Farid A, Munaretto L, et al.
Nat Biotechnol
. 2024 Jul;
PMID: 39079964
Although chimeric antigen receptor (CAR) T cell therapies have demonstrated promising clinical outcomes, durable remissions remain limited. To extend the efficacy of CAR T cells, we develop a CAR enhancer...
2.
Nili A, Daneshpazhooh M, Mahmoudi H, Kamyab K, Taraz Jamshidi S, Soleiman-Meigooni S, et al.
Dermatol Reports
. 2024 Jul;
16(2):9833.
PMID: 38979521
Worldwide, squamous cell carcinoma (SCC) incidence is rising. The literature debates the human papillomavirus (HPV)'s role in cutaneous SCC development. We examined HPV histopathology in SCC samples in this study....
3.
Uslu S, Lee U, Tavakolpour S, Abousaway O, Nili A, Bass L, et al.
ACS Pharmacol Transl Sci
. 2024 Jun;
7(6):1746-1757.
PMID: 38898944
T cells play a crucial role in antitumor immune responses and the clearance of infected cells. They identify their targets through the binding of T-cell receptors (TCRs) to peptide-major histocompatibility...
4.
Mazaherpour E, Kianfar N, Dasdar S, Sedaghat M, Seyrafi H, Balighi K, et al.
Dermatol Ther
. 2022 Oct;
35(12):e15902.
PMID: 36200713
Rituximab (RTX) combined with short-term glucocorticoids (GC) is an effective therapeutic option for pemphigus. The newly developed Glucocorticoid Toxicity Index (GTI) tool provides the possibility to measure GC toxicities over...
5.
Nili A, Karimi S, Salehi Farid A, Azar P, Farimani Z, Shahbazian H, et al.
Oral Dis
. 2022 May;
29(5):2248-2255.
PMID: 35506253
Objectives: This study determines the healing time of lesions on different locations and the contributing factors to the healing time in patients with pemphigus. Methods: In this prospective study, newly...
6.
Mortazavi S, Ghadimi E, Ardakani M, Razzaghof M, Ghasemi M, Nili A, et al.
Int Orthop
. 2022 Jan;
46(4):749-759.
PMID: 34984499
Purpose: Dislocation following total hip arthroplasty (THA) is a well-known complication. However, there is little data on its rate and predictors in patients with developmental dysplasia of the hip (DDH)....
7.
Ahangar-Sirous R, Poudineh M, Ansari A, Nili A, Alavi Dana S, Nasiri Z, et al.
CNS Neurol Disord Drug Targets
. 2021 Sep;
21(5):377-398.
PMID: 34579639
Age-related Neurological Disorders (ANDs) involve Neurodegenerative Diseases (NDDs), such as Alzheimer's Disease (AD), the most frequent kind of dementia in elderly people, and Parkinson's Disease (PD), and also other disorders...
8.
Nili A, Salehi Farid A, Asgari M, Tavakolpour S, Mahmoudi H, Daneshpazhooh M
Expert Rev Clin Immunol
. 2021 Jun;
17(8):819-834.
PMID: 34162306
: Pemphigus vulgaris (PV) is an intraepidermal autoimmune bullous disease (AIBD) characterized by autoantibodies against desmosomal adhesion proteins, most commonly desmoglein (Dsg)3, leading to the suprabasal cleft formation and acantholysis.:...
9.
Daneshpazhooh M, Tavakolpour S, Salehi Farid A, Ebadi M, Nili A, Rashidian M, et al.
Int J Dermatol
. 2021 Jun;
61(1):e14-e17.
PMID: 34156705
No abstract available.
10.
Zarei M, Tavakoli M, Ghadimi E, Moharrami A, Nili A, Vafaei A, et al.
J Orthop Surg Res
. 2021 Feb;
16(1):112.
PMID: 33546727
Background: Treatment of early-onset scoliosis (EOS) is still a challenge to patients, families, and surgeons. Previous studies have indicated that EOS patients are at high risk for complications following growth-friendly...